BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30701024)

  • 1. Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
    Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
    Oncotarget; 2018 Dec; 9(102):37689-37699. PubMed ID: 30701024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor heterogeneity of
    Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
    Oncotarget; 2018 Sep; 9(70):33337-33347. PubMed ID: 30279964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor heterogeneity: A new perspective on colorectal cancer research.
    Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
    Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
    Ai H; Song D; Wang X
    Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
    Li L; Chen C; Wang X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis.
    Yu T; Gao X; Zheng Z; Zhao X; Zhang S; Li C; Liu G
    Front Oncol; 2021; 11():744064. PubMed ID: 34722299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of trunk mutations in gastric carcinoma: a case study.
    Zhou Z; Wu S; Lai J; Shi Y; Qiu C; Chen Z; Wang Y; Gu X; Zhou J; Chen S
    BMC Med Genomics; 2017 Jul; 10(1):49. PubMed ID: 28716121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
    Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
    Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
    Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.
    McBride M; Rida PC; Aneja R
    Mol Aspects Med; 2015 Nov; 45():3-13. PubMed ID: 26024970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
    Kim M; Lee S; Lim S; Kim S
    PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GeTallele: A Method for Analysis of DNA and RNA Allele Frequency Distributions.
    Słowiński P; Li M; Restrepo P; Alomran N; Spurr LF; Miller C; Tsaneva-Atanasova K; Horvath A
    Front Bioeng Biotechnol; 2020; 8():1021. PubMed ID: 33042959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
    Park Y; Lim S; Nam JW; Kim S
    Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.
    Goto T; Hirotsu Y; Amemiya K; Mochizuki H; Omata M
    Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29932159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma.
    Li LB; Yang L; Xie GQ; Zhou XC; Shen XB; Xu QL; Ma ZY; Guo XD
    Oncol Lett; 2020 Nov; 20(5):233. PubMed ID: 32968455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Pan-Cancer Analysis of Genetic Heterogeneity Reveals Associations with Epigenetic Modifiers.
    de Matos MR; Posa I; Carvalho FS; Morais VA; Grosso AR; de Almeida SF
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30897760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
    Song D; Wang X
    J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.
    Yang F; Wang Y; Li Q; Cao L; Sun Z; Jin J; Fang H; Zhu A; Li Y; Zhang W; Wang Y; Xie H; Gustafsson JÅ; Wang S; Guan X
    Carcinogenesis; 2017 Sep; 38(9):900-909. PubMed ID: 28911002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer evolution and heterogeneity.
    Mimori K; Saito T; Niida A; Miyano S
    Ann Gastroenterol Surg; 2018 Sep; 2(5):332-338. PubMed ID: 30238073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.